No headlines found.
DNA X, Inc. Reports First Quarter 2026 Financial Results
Newsfile (Wed, 20-May 5:02 PM ET)
DNA X, Inc. Reports Full Year 2025 Financial Results
Newsfile (Tue, 14-Apr 9:36 PM ET)
DNA X Inc is engaged in providing crypto trading services through its online platform, enabling users to buy, sell, and exchange cryptocurrencies, as well as execute automated trading strategies between currency pairs. The company generates revenue from commissions and fees on trading activity.
Dna X trades on the NASDAQ stock market under the symbol SONM.
As of May 20, 2026, SONM stock price climbed to $4.48 with 7,177 million shares trading.
SONM has a beta of -0.44, meaning it tends to be less sensitive to market movements. SONM has a correlation of 0.00 to the broad based SPY ETF.
SONM has a market cap of $6.67 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, SONM traded as high as $234.00 and as low as $2.52.
The top ETF exchange traded funds that SONM belongs to (by Net Assets): VXF.
SONM has underperformed the market in the last year with a price return of -75.0% while the SPY ETF gained +25.9%. SONM has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -10.7% and -8.6%, respectively, while the SPY returned +8.6% and +2.4%, respectively.
SONM support price is $3.89 and resistance is $4.71 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SONM shares will trade within this expected range on the day.